Integris Wealth Management’s AbbVie ABBV Stock Holding History

Integris Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	5,581 +675	+14%	+$145K	0.28%	30
2026 Q1	$1.07M	Sell	4,906 -132	-3%	-$29.3K	0.25%	34
2025 Q4	$1.15M	Sell	5,038 -91	-2%	-$20.7K	0.26%	35
2025 Q3	$1.19M	Sell	5,129 -264	-5%	-$53.8K	0.29%	33
2025 Q2	$1M	Buy	5,393 +283	+6%	+$52.6K	0.26%	35
2025 Q1	$1.07M	Sell	5,110 -54	-1%	-$10.5K	0.31%	29
2024 Q4	$918K	Buy	5,164 +259	+5%	+$47.6K	0.26%	32
2024 Q3	$969K	Buy	4,905 +312	+7%	+$58.2K	0.27%	31
2024 Q2	$788K	Sell	4,593 -46	-1%	-$7.62K	0.23%	35
2024 Q1	$845K	Buy	4,639 +203	+5%	+$35K	0.23%	34
2023 Q4	$687K	Buy	4,436 +46	+1%	+$6.71K	0.2%	39
2023 Q3	$654K	Buy	4,390 +128	+3%	+$18.8K	0.21%	40
2023 Q2	$574K	Hold	4,262	–	–	0.2%	39
2023 Q1	$679K	Hold	4,262	–	–	0.25%	36
2022 Q4	$689K	Buy	+4,262	New	+$654K	0.27%	33

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Integris Wealth Management's ABBV Position: Q2 2026 in Review

Integris Wealth Management increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $145K and bringing the position to 5,581 shares worth $1.4M. The position accounts for 0.28% of the portfolio, ranked #30.

Integris Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Integris Wealth Management held 5,581 shares of AbbVie worth $1.4M as of Q2 2026.
Integris Wealth Management bought 675 AbbVie shares in Q2 2026, an estimated $145K.
AbbVie made up 0.28% of Integris Wealth Management's portfolio in Q2 2026, its #30 holding.
Integris Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Integris Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.